文献速递呼吸衰竭与机械通气儿科与产科急症

婴儿急性毛细支气管炎俯卧位通气:PROPOSITIS随机临床试验

Prone Positioning in Infants With Acute Bronchiolitis: The PROPOSITIS Randomized Clinical Trial.
PubMed 文献 · JAMA · 2026-01-01
一句话结论中重度急性毛细支气管炎婴儿接受高流量鼻导管支持时,俯卧位未显著减少72小时内升级至无创或有创通气的比例(15.0% vs 20.8%,校正OR 0.66,95%CI 0.40-1.07,P=0.09)。

该多中心、随机、开放标签试验在法国15个儿科中间或重症监护病房纳入451例6月龄及以下、因中重度急性毛细支气管炎需要高流量鼻导管支持(2 L/kg/min)的婴儿。俯卧位组(n=221)在最初48小时内接受俯卧位至少24小时,对照组(n=230)取仰卧位。主要终点72小时内升级至无创或有创通气的比例在俯卧位组为15.0%(33/220),仰卧位组为20.8%(47/226),校正OR 0.66(95%CI 0.40-1.07),P=0.09,无显著差异;次要终点亦无显著差异。作者结论认为俯卧位未显著减少升级治疗,但置信区间较宽提示研究非确定性结论,需进一步研究。

要点

  • 中重度毛细支气管炎婴儿接受高流量鼻导管(2 L/kg/min)时,俯卧位组72小时内升级至无创或有创通气15.0%(33/220) vs 仰卧位组20.8%(47/226),校正OR 0.66(95%CI 0.40-1.07),P=0.09,未达统计学显著。
  • 俯卧位组在最初48小时内接受俯卧位至少24小时,与仰卧位相比次要终点(治疗失败、住院时长、呼吸支持时长、婴儿舒适度、不良事件)均无显著差异。
  • 安全性分析中,俯卧位组严重不良事件2/180(1.1%),仰卧位组2/264(0.8%)。
  • 作者结论:俯卧位未显著减少升级治疗,但95%CI较宽提示研究非确定性结论,需进一步研究。

适用人群与场景

  • 6月龄及以下婴儿,因急性毛细支气管炎诊断入院24小时以内,存在中重度呼吸窘迫并需要高流量鼻导管支持者。
  • 研究在法国15个儿科中间或重症监护病房进行,纳入时间为2021年1月至2023年11月,随访至出院(最后一名患者出院日期为2023年12月11日)。

处置流程与药物剂量

  • 所有参与者接受标准化高流量鼻导管支持,流量为2 L/kg/min。
  • 俯卧位组在最初48小时内接受俯卧位至少24小时。

研究设计与关键结果

  • 多中心、随机、开放标签试验,在法国15个儿科中间或重症监护病房纳入451例婴儿,446例纳入主要分析(中位年龄41天,IQR 19-72天;54%男性)。
  • 主要终点72小时内升级至无创或有创通气:俯卧位组33/220(15.0%) vs 仰卧位组47/226(20.8%),校正OR 0.66(95%CI 0.40-1.07),P=0.09,无显著差异。
  • 次要终点(治疗失败、俯卧位耐受性、住院时长、呼吸支持时长、婴儿舒适度、不良事件)两组间均无显著差异。
  • 安全性分析:严重不良事件俯卧位组2/180(1.1%) vs 仰卧位组2/264(0.8%)。

证据类型、等级与局限

  • 证据类型:多中心、随机、开放标签临床试验。
  • 局限:作者指出95%置信区间较宽,提示该研究为非确定性结论,需进一步研究。

对床旁实践的改变

  • 对于6月龄及以下中重度急性毛细支气管炎接受高流量鼻导管(2 L/kg/min)的婴儿,俯卧位未显著减少72小时内升级至无创或有创通气,两组次要终点亦无显著差异。
  • 作者认为该研究为非确定性结论,需进一步研究。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Prone positioning has been shown to improve respiratory mechanics and oxygenation, but its clinical benefit in infants with acute viral bronchiolitis receiving high-flow nasal cannula (HFNC) support remains unknown.

OBJECTIVE: To investigate whether prone positioning in infants with moderate to severe acute bronchiolitis and HFNC support reduces escalation to noninvasive or invasive ventilation.

DESIGN, SETTING, AND PARTICIPANTS: Multicenter, randomized, open-label trial conducted in 15 pediatric intermediate or intensive care units in France. Infants aged 6 months or younger admitted for 24 hours or less with a diagnosis of acute bronchiolitis with moderate to severe respiratory distress requiring HFNC support were enrolled between January 2021 and November 2023 and followed up until hospital discharge (last patient discharged on December 11, 2023).

INTERVENTIONS: Participants were randomly assigned to the prone position (n = 221) or supine position (n = 230). Infants in the prone position group received prone positioning for 24 hours or longer during the first 48 hours. All participants received standardized HFNC support at 2 L/kg/min.

MAIN OUTCOMES AND MEASURES: The primary outcome was the need for escalation of care to noninvasive or invasive ventilation within the first 72 hours, according to prespecified criteria. Secondary outcomes included treatment failure, determined by an independent clinical adjudication committee; tolerance of prone positioning; length of hospital stay; duration of respiratory support; infant comfort; and adverse events.

RESULTS: Among 451 infants randomized, 446 were included in the primary analysis (median age, 41 [IQR, 19-72] days; 54% male). Escalation of care occurred in 80 infants (17.9%), with no significant difference between the prone position (33/220 [15.0%]) and supine position (47/226 [20.8%]) groups (adjusted odds ratio, 0.66 [95% CI, 0.40-1.07]; P = .09). Secondary outcomes did not differ significantly between the 2 groups. In the safety analysis, serious adverse events occurred in 2 of 180 infants (1.1%) in the prone position group and 2 of 264 (0.8%) in the supine position group.

CONCLUSIONS AND RELEVANCE: Prone positioning in infants with moderate to severe bronchiolitis receiving HFNC support did not significantly reduce escalation of care. However, the wide 95% confidence interval around the observed odds ratio suggests that this study was not definitive and further research is warranted.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03976895.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Baudin F, Pouyau R, Subtil F, et al. Prone Positioning in Infants With Acute Bronchiolitis: The PROPOSITIS Randomized Clinical Trial. JAMA. 2026. PMID: 42307570. doi:10.1001/jama.2026.11078

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。